Apatinib in metastatic gastric cancer: can paclitaxel make the difference?

被引：4
|
作者：
Roviello, Giandomenico [1 ,2 ]
Roviello, Franco [3 ]
Polom, Karol [3 ]
Generalli, Daniele [2 ,4 ]
机构：
[1] Univ Brescia, Dept Mol & Translat Med, Viale Europa 11, I-25124 Brescia, Italy
[2] AO Azienda Ist Ospitalieri Cremona, Unit Mol Therapy & Pharmacogen, Viale Concordia, Cremona, Italy
[3] Univ Siena, Unit Gen & Minimally Invas Surg, Surg & Neurosci, Viale Bracci, Siena, Italy
[4] Univ Trieste, Dept Med Surg & Hlth Sci, Piazza Ospitale, Trieste, Italy
来源：
ANTI-CANCER DRUGS | 2016年 / 27卷 / 08期
关键词：
GASTROESOPHAGEAL JUNCTION; PHASE-3; TRIAL; DOUBLE-BLIND; ADENOCARCINOMA;
D O I：
10.1097/CAD.0000000000000380
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：809 / 809
页数：1
相关论文
共 50 条
  • [41] LEADERSHIP - IT CAN MAKE A DIFFERENCE
    SMITH, JE
    CARSON, KP
    ALEXANDER, RA
    ACADEMY OF MANAGEMENT JOURNAL, 1984, 27 (04): : 765 - 776
  • [42] CAN SCHOOLS MAKE A DIFFERENCE
    HOLTZ, BW
    TEACHERS COLLEGE RECORD, 1981, 83 (02): : 300 - 307
  • [43] WORDS CAN MAKE THE DIFFERENCE
    CROSBY, M
    ELEMENTARY ENGLISH, 1960, 37 (02): : 81 - 85
  • [44] The prognostic value of baseline hematological parameters of peripheral blood in metastatic gastric cancer treated with apatinib
    Yang, Jin-Ru
    Zhou, Dan-Yang
    Wu, Ying
    Zhu, Ying
    Lin, Zhen-Yu
    Zhang, Tao
    Yu, Dan-Dan
    JOURNAL OF CANCER, 2022, 13 (01): : 15 - 20
  • [45] Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL-17
    Chen, Ran
    Chen, Qi-Tian
    Dong, You-Hong
    ONCOLOGY LETTERS, 2019, 17 (06) : 5447 - 5452
  • [46] Apatinib as an optional treatment in metastatic colorectal cancer
    Li, Aiyi
    Wang, Kong
    Xu, Aiguo
    Wang, Gang
    Miao, Yongchang
    Sun, Zhichao
    Zhang, Jingyu
    MEDICINE, 2019, 98 (35) : e16919
  • [47] Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway
    Bei, Yanping
    Chen, Xue
    Xu, Quan
    Lv, Jiaming
    Hu, Jing
    Yang, Shaohui
    DRUG DEVELOPMENT RESEARCH, 2022, 83 (02) : 379 - 388
  • [48] A phase II study of apatinib on reversing resistance of paclitaxel-containing regimens in advanced gastric cancer (AGC).
    Lin, Rongbo
    Li, Hui
    Liu, Jie
    Zhao, Shen
    Yu, Jiaqing
    Fan, Nanfeng
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] Camrelizumab combined with apatinib and albumin-bound paclitaxel followed by camrelizumab plus apatinib as first-line therapy for unresectable or metastatic pancreatic cancer.
    Shen, Bo
    Wu, Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 703 - 703
  • [50] Make IT matter: How computing can make a difference
    Abowd, Gregory D.
    SIGCSE Bulletin Inroads, 2009, 41 (01):
12345